{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:03:27Z","timestamp":1791558207998,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,6,17]],"date-time":"2013-06-17T00:00:00Z","timestamp":1371427200000},"content-version":"vor","delay-in-days":717,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.cca.2011.04.006","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T06:58:20Z","timestamp":1303282700000},"page":"1366-1370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Urinary 11-dehydro thromboxane B2 levels in type 2 diabetic patients before and during aspirin intake"],"prefix":"10.1016","volume":"412","author":[{"given":"Lillian Harboe","family":"Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luci Maria Sant'Ana","family":"Dusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Braga","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirelle Oliveira","family":"S\u00f3ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Teodoro","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryna Fontana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Rocha","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Komatsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinez Oliveira","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Aparecida","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rson Ant\u00f4nio","family":"Pianett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria das Gra\u00e7as","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.04.006_bb0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/dc07-9917","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus. A scientific statement from the American Heart Association and the American Diabetes Association","volume":"30","author":"Buse","year":"2007","journal-title":"Diabetes care"},{"key":"10.1016\/j.cca.2011.04.006_bb0010","series-title":"American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","first-page":"199S","article-title":"Antiplatelet drugs","volume":"133","author":"Patrono","year":"2008"},{"key":"10.1016\/j.cca.2011.04.006_bb0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2011.04.006_bb0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0049-3848(87)90103-4","article-title":"Paired analysis of urinary thromboxane B2 metabolites in humans","volume":"47","author":"Catella","year":"1987","journal-title":"Thromb Res"},{"key":"10.1016\/j.cca.2011.04.006_bb0025","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2011.04.006_bb0030","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2011.04.006_bb0035","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.108.768283","article-title":"Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid. Determinants and effect on cardiovascular risk","volume":"118","author":"Eikelboom","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2011.04.006_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.diabres.2009.09.029","article-title":"Aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cca.2011.04.006_bb0045","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/dc08-0282","article-title":"Hyperglycemia is associated with enhanced thrombin formation, platelet activation and fibrin clot resistance to lysis in patients with acute coronary syndrome","volume":"31","author":"Undas","year":"2008","journal-title":"Diabetes Care"},{"issue":"784","key":"10.1016\/j.cca.2011.04.006_bb0050","first-page":"e1","article-title":"The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy","volume":"158","author":"Singla","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2011.04.006_bb0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jdiacomp.2007.05.002","article-title":"Aspirin resistance associated with HbA1c and obesity in diabetic patients","volume":"22","author":"Cohen","year":"2008","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.cca.2011.04.006_bb0060","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1210\/jc.2009-2392","article-title":"Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus","volume":"95","author":"Ertugrul","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2011.04.006_bb0065","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0735-1097(03)00921-5","article-title":"Resistance in vitro to low-dose aspirin is associated with platelet P1A1 (GP IIIa) polymorphism but not with C807T (GP Ia\/IIa) and C-5T Kozak (GP Ib\u03b1) polymorphisms","volume":"42","author":"Macchi","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2011.04.006_bb0070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ahj.2004.10.007","article-title":"The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis","volume":"149","author":"Pamukcu","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2011.04.006_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jdiacomp.2007.06.003","article-title":"Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia","volume":"23","author":"Le Guyader","year":"2009","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.cca.2011.04.006_bb0080","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1067\/mcp.2003.1","article-title":"Genetic variation in ciclooxygenase 1: effects on response to aspirin","volume":"73","author":"Haluska","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cca.2011.04.006_bb0085","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1111\/j.1538-7836.2005.01555.x","article-title":"Cyclooxygenase-1 haplotype modulates platelet response to aspirin","volume":"3","author":"Maree","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cca.2011.04.006_bb0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1160\/TH05-07-0516","article-title":"Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients","volume":"95","author":"Lepantalo","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cca.2011.04.006_bb0095","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2011.04.006_bb0100","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1538-7836.2005.01119.x","article-title":"Variability in response to aspirin: do we understand the clinical relevance?","volume":"3","author":"Campbell","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cca.2011.04.006_bb0105","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2011.04.006_bb0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2337\/dc09-1701","article-title":"Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting. The Fremantle Diabetes Study","volume":"33","author":"Ong","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2011.04.006_bb0115","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/diacare.29.s1.06.s43","article-title":"Diagnosis and classification of diabetes mellitus","volume":"29","author":"American Diabetes Association","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2011.04.006_bb0120","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/hc4701.099787","article-title":"PI(A2) polymorphism of \u03b23 integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury","volume":"104","author":"Undas","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2011.04.006_bb0125","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s10620-006-9475-8","article-title":"Effect of a specific cyclooxygenase-gene polymorphism (A-842G\/C50T) on the occurrence of peptic ulcer hemorrhage","volume":"51","author":"Van Oijen","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cca.2011.04.006_bb0130","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/dc10-0555","volume":"33","author":"Pignone","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2011.04.006_bb0135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/EJA.0b013e328335b354","article-title":"Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients","volume":"27","author":"Zisman","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.cca.2011.04.006_bb0140","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1016\/j.thromres.2009.11.016","article-title":"Post interventional cardiology urinary thromboxane correlates with PlateletMapping\u00ae detected aspirin resistance","volume":"125","author":"Carrol","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.cca.2011.04.006_bb0145","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0140-6736(98)05054-5","article-title":"Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation","volume":"353","author":"Undas","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2011.04.006_bb0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1160\/TH08-11-0753","article-title":"Cyclooxigenase-1 haplotype C50T\/A-842G does not affect platelet response to aspirin","volume":"101","author":"Pettinella","year":"2009","journal-title":"Thromb Haemost"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111002002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111002002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:43:32Z","timestamp":1757861012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":30,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0009898111002002"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.04.006","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary 11-dehydro thromboxane B2 levels in type 2 diabetic patients before and during aspirin intake","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2011.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}